FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1632-1633 December 14, 1995 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Ischemic stroke may occur with sudden cruelty and, when not fatal, may deplete the resources of the patient, family, and community. The most effective treatments are directed at the underlying causes of the initial ischemic event, the prevention of recurrence, and the reduction of potential risk factors, but they do little for the stroke itself. The majority of ischemic strokes, roughly 80 percent, result from thromboembolic or atherothrombotic processes. This underscores the fact that stroke is a vascular disorder with neurologic consequences, and provides a basis for the use of antithrombotic agents as therapy. The idea of using plasminogen activators . . . [Full Text of this Article]

References

Related Letters:

Tissue Plasminogen Activator for Acute Ischemic Stroke
Friedman H. S., Koroshetz W. J., The Massachusetts General Hospital Stroke Service , Qureshi N., Marler J. R., The NINDS-PA Stroke Study Group , del Zoppo G. J.
Extract | Full Text  
N Engl J Med 1996; 334:1405-1406, May 23, 1996. Correspondence

This article has been cited by other articles:

• Davis, M., Barer, D. (1999). Neuroprotection in acute ischaemic stroke. II: Clinical potential. Vasc Med 4: 149-163 [Abstract]  
• Choudhri, T. F., Hoh, B. L., Prestigiacomo, C. J., Huang, J., Kim, L. J., Schmidt, A. M., Kisiel, W., Connolly, E. S. Jr., Pinsky, D. J. (1999). Targeted Inhibition of Intrinsic Coagulation Limits Cerebral Injury in Stroke without Increasing Intracerebral Hemorrhage. JEM 190: 91-100 [Abstract] [Full Text]  
• Grond, M., Stenzel, C., Schmulling, S., Rudolf, J., Neveling, M., Lechleuthner, A., Schneweis, S., Heiss, W.-D. (1998). Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach. Stroke 29: 1544-1549 [Abstract] [Full Text]  
• Connolly, E. S. Jr, Winfree, C. J., Prestigiacomo, C. J., Kim, S. C., Choudhri, T. F., Hoh, B. L., Naka, Y., Solomon, R. A., Pinsky, D. J. (1997). Exacerbation of Cerebral Injury in Mice That Express the P-Selectin Gene : Identification of P-Selectin Blockade as a New Target for the Treatment of Stroke. Circ. Res. 81: 304-310 [Abstract] [Full Text]  
• Larrue, V., von Kummer, R., del Zoppo, G., Bluhmki, E. (1997). Hemorrhagic Transformation in Acute Ischemic Stroke : Potential Contributing Factors in the European Cooperative Acute Stroke Study. Stroke 28: 957-960 [Abstract] [Full Text]  
• Riggs, J. E. (1997). Tissue-Type Plasminogen Activator Should Not Be Used in Acute Ischemic Stroke. Arch Fam Med 6: 102-104 [Abstract]  
• Riggs, J. E. (1996). Tissue-Type Plasminogen Activator Should Not Be Used in Acute Ischemic Stroke. Arch Neurol 53: 1306-1308 [Abstract]  
• Adams, H. P., Brott, T. G., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Kwiatkowski, T., Lyden, P. D., Marler, J. R., Torner, J., Feinberg, W., Mayberg, M., Thies, W. (1996). Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94: 1167-1174 [Full Text]  
• Joynt, R. J. (1996). Neurology. JAMA 275: 1826-1827 [Abstract]  
• Friedman, H. S., Koroshetz, W. J., The Massachusetts General Hospital Stroke Service, , Qureshi, N., Marler, J. R., The NINDS-PA Stroke Study Group, , del Zoppo, G. J. (1996). Tissue Plasminogen Activator for Acute Ischemic Stroke. NEJM 334: 1405-1406 [Full Text]